×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Take Care Before Diving Into The Deep End On Incyte Corporation (NASDAQ:INCY)
Simply Wall Street
There wouldn't be many who think Incyte Corporation's ( NASDAQ:INCY ) price-to-earnings (or "P/E") ratio of 16x is...
12 hours ago
Leo Pharma prepares to come for the topical JAK market as Incyte's Opzelura cream launch cools off
Fierce Pharma
Watch out, Incyte. Leo Pharma and its JAK inhibitor cream delgocitinib are coming to disrupt the topical atopic dermatitis market,...
17 hours ago
Incyte Corp. stock rises Thursday, still underperforms market
MarketWatch
Shares of Incyte Corp. inched 0.28% higher to $53.09 Thursday, on what proved to be an all-around great trading session for the stock market...
1 day ago
Incyte to Present at Upcoming Investor Conference
Business Wire
Incyte (Nasdaq:INCY) announced today that it will present at the Bank of America Securities 2024 Health Care Conference on Wednesday,...
1 day ago
Incyte Inks $750M Deal to Buy Escient and Skin Disease Drug Candidates
BioSpace
Published: Apr 23, 2024 By Nick Paul Taylor. Incyte_iStock, Bo Shen. Pictured: Incyte building in Wilmington, Delaware/iStock, Bo Shen.
1 week ago
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Fierce Biotech
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Therapeutics for $750 million.
1 week ago
Incyte: Q1 Earnings Snapshot
qz.com
WILMINGTON, Del. (AP) — WILMINGTON, Del. (AP) — Incyte Corp. (INCY) on Tuesday reported first-quarter profit of $169.5 million.
3 days ago
Incyte (INCY) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Yahoo Finance
While the top- and bottom-line numbers for Incyte (INCY) give a sense of how the business performed in the quarter ended March 2024,...
3 days ago
Incyte (INCY) Misses Q1 EPS by 18c ; Offers Guidance
StreetInsider
Incyte (NASDAQ: INCY) reported Q1 EPS of $0.64, $0.18 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $880.89...
3 days ago
Incyte Corporation 2024 Q1 - Results - Earnings Call Presentation (NASDAQ:INCY)
Seeking Alpha
The following slide deck was published by Incyte Corporation in conjunction with their 2024 Q1 earnings call.
3 days ago